NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Accelr8 Technology Corporation

Accelr8 Technology Corporation

Overview

An in-vitro diagnostics company that provides solutions for the rapid diagnosis of serious infections to address the global challenges of antibiotic resistance and sepsis. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. In May 2025, the company initiated a voluntary Chapter 11 restructuring proceeding.

Portfolio Companies

4

Investments

Accelr8 Technology Corporation investments
CompanyDateStageLead
Elo Life SystemsJan 2024Series A ExtensionCo-investor
Andes Ag, Inc.Mar 2023Series A ExtensionCo-investor
Elo Life SystemsFeb 2023Series ALead
Andes Ag, Inc.Sep 2021Series ACo-investor
BlocPowerFeb 2021Series ALead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersTucson, Arizona
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.